Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year
Sixteen major drug firms raised prices by a median of 4% in January despite deals aimed at lowering costs, with some discounts benefiting Medicaid and cash-paying patients.
7 Articles
7 Articles
Today in 'great' America: Donald Trump decides to prove he can't negotiate to save his life
Despite striking voluntary deals with the Trump administration aimed at lowering consumer costs, all 16 major pharmaceutical companies involved immediately rolled out price hikes this January. This is a truly awful look for the administration’s negotiation strategy, especially considering the deals were announced with major fanfare starting back in September. The trend of price hikes typically hits in January, but these specific increases make t…
Trump cut deals with 16 drug companies to lower prices, but they're already ignoring those expectations
Despite a highly publicized push by President Donald Trump to reduce drug costs, all 16 pharmaceutical companies that signed voluntary pricing agreements with the administration raised prices on some products. The development was first reported by NPR, which reviewed new pricing data released at the start of the year. Since September, those companies agreed to curb costs under a voluntary framework promoted by the White House. January is typical…
Trump struck deals with 16 drug companies. But they're still raising prices this year - TPR: The Public's Radio
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026. The post Trump struck deals with 16 drug companies. But they’re still raising prices this year appeared first on TPR: The Public's Radio.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium




